位置:首页 > 蛋白库 > IF16_PONAB
IF16_PONAB
ID   IF16_PONAB              Reviewed;         785 AA.
AC   Q5RD14;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   20-MAY-2008, sequence version 2.
DT   25-MAY-2022, entry version 93.
DE   RecName: Full=Gamma-interferon-inducible protein 16;
DE            Short=Ifi-16;
DE   AltName: Full=Interferon-inducible myeloid differentiation transcriptional activator;
GN   Name=IFI16;
OS   Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Pongo.
OX   NCBI_TaxID=9601;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RG   The German cDNA consortium;
RL   Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Binds double-stranded DNA. Binds preferentially to
CC       supercoiled DNA and cruciform DNA structures. Seems to be involved in
CC       transcriptional regulation. May function as a transcriptional
CC       repressor. Could have a role in the regulation of hematopoietic
CC       differentiation through activation of unknown target genes. Controls
CC       cellular proliferation by modulating the functions of cell cycle
CC       regulatory factors including p53/TP53 and the retinoblastoma protein.
CC       May be involved in TP53-mediated transcriptional activation by
CC       enhancing TP53 sequence-specific DNA binding and modulating TP53
CC       phosphorylation status. Seems to be involved in energy-level-dependent
CC       activation of the ATM/ AMPK/TP53 pathway coupled to regulation of
CC       autophagy. May be involved in regulation of TP53-mediated cell death
CC       also involving BRCA1. May be involved in the senescence of prostate
CC       epithelial cells. Involved in innate immune response by recognizing
CC       viral dsDNA in the cytosol and probably in the nucleus. After binding
CC       to viral DNA in the cytoplasm recruits TMEM173/STING and mediates the
CC       induction of IFN-beta. Has anti-inflammatory activity and inhibits the
CC       activation of the AIM2 inflammasome, probably via association with
CC       AIM2. Proposed to bind viral DNA in the nucleus and to induce the
CC       formation of nuclear caspase-1-activating inflammasome formation via
CC       association with PYCARD. Inhibits replication of herpesviruses probably
CC       by interfering with promoter recruitment of members of the Sp1 family
CC       of transcription factors (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Forms homooligomers. Interacts with TMEM173, AIM2, PYCARD and
CC       CASP1. Interacts with BRCA1, TP53, E2F1, RB1 and SP1. Interacts with
CC       MTA1 (By similarity). Interacts with MTA1. Interacts with PYDC5 (By
CC       similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q16666}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}.
CC   -!- DOMAIN: The HIN-20 domains mediates dsDNA binding via electrostatic
CC       interactions. {ECO:0000250}.
CC   -!- PTM: Lysine acetylation in the multipartite nuclear localization signal
CC       (NLS) regulates the subcellular location. {ECO:0000250}.
CC   -!- PTM: Phosphorylated on Ser and Thr. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the HIN-200 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAH90343.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CR858104; CAH90343.1; ALT_INIT; mRNA.
DR   RefSeq; NP_001125164.1; NM_001131692.1.
DR   AlphaFoldDB; Q5RD14; -.
DR   SMR; Q5RD14; -.
DR   STRING; 9601.ENSPPYP00000000774; -.
DR   GeneID; 100172051; -.
DR   KEGG; pon:100172051; -.
DR   CTD; 3428; -.
DR   eggNOG; ENOG502QTQS; Eukaryota.
DR   HOGENOM; CLU_022874_0_0_1; -.
DR   InParanoid; Q5RD14; -.
DR   OrthoDB; 1304994at2759; -.
DR   TreeFam; TF337385; -.
DR   Proteomes; UP000001595; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0002218; P:activation of innate immune response; IEA:InterPro.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0035458; P:cellular response to interferon-beta; IEA:InterPro.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.533.10; -; 1.
DR   Gene3D; 2.40.50.140; -; 4.
DR   InterPro; IPR004020; DAPIN.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR040205; HIN-200.
DR   InterPro; IPR004021; HIN200/IF120x.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   PANTHER; PTHR12200; PTHR12200; 2.
DR   Pfam; PF02760; HIN; 2.
DR   Pfam; PF02758; PYRIN; 1.
DR   SMART; SM01289; PYRIN; 1.
DR   PROSITE; PS50824; DAPIN; 1.
DR   PROSITE; PS50834; HIN_200; 2.
PE   2: Evidence at transcript level;
KW   Acetylation; Activator; Apoptosis; Autophagy; Cytoplasm; DNA-binding;
KW   Immunity; Inflammatory response; Innate immunity; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..785
FT                   /note="Gamma-interferon-inducible protein 16"
FT                   /id="PRO_0000334523"
FT   DOMAIN          5..92
FT                   /note="Pyrin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00061"
FT   DOMAIN          193..393
FT                   /note="HIN-200 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00106"
FT   DOMAIN          566..765
FT                   /note="HIN-200 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00106"
FT   REGION          88..196
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          192..393
FT                   /note="Interaction with TP53 C-terminus"
FT                   /evidence="ECO:0000250"
FT   REGION          388..442
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          571..766
FT                   /note="Interaction with TP53 core domain"
FT                   /evidence="ECO:0000250"
FT   MOTIF           96..100
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250"
FT   MOTIF           128..131
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250"
FT   MOTIF           134..136
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250"
FT   MOTIF           140..143
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        106..120
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        123..142
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        164..191
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         45
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16666"
FT   MOD_RES         95
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16666"
FT   MOD_RES         99
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16666"
FT   MOD_RES         106
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16666"
FT   MOD_RES         128
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q16666"
FT   MOD_RES         168
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16666"
FT   MOD_RES         174
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16666"
FT   MOD_RES         214
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16666"
FT   MOD_RES         444
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16666"
FT   MOD_RES         451
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16666"
FT   MOD_RES         575
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16666"
FT   MOD_RES         598
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16666"
FT   MOD_RES         614
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16666"
FT   MOD_RES         780
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16666"
FT   CROSSLNK        116
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16666"
FT   CROSSLNK        128
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q16666"
FT   CROSSLNK        683
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16666"
SQ   SEQUENCE   785 AA;  88381 MW;  C40FAF54C9A455C1 CRC64;
     MEKKYKNIVL LKGLEVINDY HFRMVKSLLS NDLKLNLKMR EEYDKIQIAD LMEEKFRGDA
     GLGKLIQIFK DIPTLEDLAE TLKKEKLKAK GLAPSRKRKK EVDAASPAPS TSSTVKTEGA
     EATPGAQKRK KTTKEKSGPK GSKVSKEQTQ PPCPAGAGMS TAMGRSPSPK TSSSAPPNTS
     STENPKTVAK CQATPRRSVL QKGPVIVKVL STTKPFEYET PEMEKKIMFH ATVATQTQFF
     HVKVLNTSLK EKFNGKKIII ISDYLEYDSL LEVNEESTVS EAGPNQKFEV PNKIINRAKE
     TLKIDILHKQ ASGNIVYGVF TLHKKTVNQK TTIYKIQDDR GKMDVVGTGQ CHNIPCEEGD
     KLQLYCFRLR KKNQMSTLIS EMHSFIQIKK KTNPRNNDPK SMKLPQEQSQ LPNPSEAGTT
     FPESHLWTPQ MPPTTPSSSF FTKKSEDTIS KMNDFMRMQI LKEESHFPGP FMTSIGPAES
     YPHTPQMPPS TPSSSFLTTK SEDTISKMND FMRMQILKEE SHFPRPFMTS IGPAESYPHT
     PQMPPSTPSS SFLTTWKPKL QTEPEEVSIE DSAQSDLKEV MVLNATESFV YEPKEQKKMF
     HATVATEKEV FRVKVFNIDL KEKFTPKKII AISNYVCRNG FLEVYPFTLV ADVNADPKME
     IPKGLIRSAN ITPKINQLCS QTKGSFVNGV FEVHKKNVRG EFTYYEIQDN TGKMEVVVHG
     RLTTINCEEG DKLKLTCFEL APKSGNTGEL RSVIHSHIKV IKTRKNKKDI LNPDSSMETS
     PDFFF
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024